如何测量血糖水平的变化? 一个文学评论
Sandra Lazar1,2,3, Ioana Ionita1,2, Delia Reurean-Pintilei3,4
1First Department of Internal Medicine, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Medicina (Kaunas, Lithuania)
|January 23, 2024
概括
最佳的糖尿病管理需要监测血糖变化,而不仅仅是血红蛋白A1c. 持续的葡萄糖监测系统提供关键指标,以评估血糖波动和预防并发症.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 糖尿病管理 糖尿病管理
背景情况:
- 最佳的糖尿病管理旨在控制血糖,没有并发症.
- 仅仅血红蛋白A1c是不够的;血糖的波动显著影响微型和宏观的血管共同疾病.
- 持续血糖监测 (CGM) 系统量化了血糖的变化.
研究的目的:
- 突出血糖变异在糖尿病管理中的重要性.
- 为了更好地了解常见和替代的血糖变化指标.
- 为了告知临床实践关于评估超出HbA1c的血糖控制.
主要方法:
- 审查最近关于血糖监测和糖尿病并发症的研究.
- 分析来自连续血糖监测系统的数据.
- 描述和比较各种血糖变化指标.
主要成果:
- 通过CGM量化的血糖波动对于预测糖尿病相关并发症至关重要.
- 标准的血糖控制指标可能无法捕捉出血糖变化的全部影响.
- 来自CGM的各种指标提供了对血糖控制的更全面的看法.
结论:
- 血糖的变化是糖尿病管理和并发症发展的关键因素.
- 持续血糖监测系统及其相关指标提供了有价值的见解.
- 临床医生应考虑对血糖变异性的评估,以改善患者的治疗结果.
相关概念视频
Variability: Analysis
143
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
The range is a simple measure of variability, indicating the difference between the highest and...
143
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Hypoglycemia and Glucagon
263
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
263
Overview of Carbohydrate Metabolism
1.1K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.1K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
176
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
176


